The serum concentrations of sVCAM-1 and MCP-1 in RA patients were especially diminished after 15 months of treatment with TNFαI (both p <0.05; Figure 3a,c) and were no longer different from the control values (p = 0.774 and p = 0.159, respectively; Table 3). Here, CCL2 is linked to rheumatoid arthritis.